T. +31 649 998 203 | +34 944 008 847 ( IES Medical )

Weber et al. Flow-controlled ventilation improves gas exchange in lung-healthy patients – a randomised interventional cross-over study. Acta Anaesthesiol Scand. 2019 Dec 12. doi: 10.1111/aas.13526. [Epub]

The workgroup of Prof. Schumann performed a crossover randomized controlled trial in lung-healthy patients comparing FCV to VCV. They revealed a higher efficiency of ventilation when using FCV, even after short-term application. With similar ventilation settings, FCV resulted in a 9% higher arterial oxygenation and 5% lower arterial CO2 concentration (P<0.001). The mean tracheal pressure was higher during FCV (+10 %; P<0.001), with comparable tidal volumes, inspiratory plateau pressure and end-expiratory pressure. This study indicates that FCV shows potential benefits to allow lung protective ventilation.

Get back to Literature

SEE OUR PRODUCTS

  • Tritube
  • Cricath
  • Evone
  • Ventrain

BLOG/NEWS

  • Evone is the best thing ever (read more..)
  • Ventrain is the greatest thing (read more..)
  • etc
  • etc

LITERATURE

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s,

CONTACT US

Ventinova Medical
Meerenakkerplein 7
5652 BJ Eindhoven (NL)

T. +31 (0)40 7516020
E. info@ventinova.nl